TRAIL is a member of the tumor necrosis factor superfamily that selectively induces apoptosis in a wide variety of cancer cells, while sparing normal cells, highlighting its potential as an agent for cancer therapy[1]. The gene discussed is TNFSF10; the disease is cancer.